Yellow Plaques on Skin (Xanthomas) - Causes, Treatment & When to See a Doctor

What is Yellow Plaques on Skin (Xanthomas)?

Xanthomas are firm, yellow‑to‑orange plaques or nodules that develop in the skin, tendons, or other tissues because of an abnormal buildup of lipids (fats) within cells called macrophages. The word “xanthoma” comes from the Greek *xanthos* meaning “yellow.” While the lesions themselves are usually painless and harmless, they often signal an underlying disturbance in cholesterol, triglyceride, or other lipid metabolism pathways.

Common Causes

Not every yellow plaque means a serious disease, but many systemic conditions produce xanthomas. The most frequent culprits include:

• Familial hypercholesterolemia (FH) – an inherited defect in LDL‑receptor function leading to very high LDL‑cholesterol.
• Familial combined hyperlipidemia – elevated LDL, VLDL, and triglycerides.
• Type IIb hyperlipoproteinemia – mixed elevation of LDL and VLDL.
• Type III dysbetalipoproteinemia – abnormal ApoE2 homozygosity causing accumulation of remnant particles.
• Type IV hypertriglyceridemia – markedly high triglycerides, often linked to pancreatitis.
• Secondary causes such as uncontrolled diabetes mellitus, obesity, hypothyroidism, or nephrotic syndrome.
• Drug‑induced lipid disorders – especially effects of glucocorticoids, protease inhibitors, or some immunosuppressants.
• Liver disease – cholestatic disorders may cause “xanthoma striatum palmare” (yellow streaks on the palms).
• Granulomatous diseases – e.g., sarcoidosis, where lipid‑laden macrophages accumulate in the skin.
• Rare systemic disorders – such as Niemann‑Pick disease or sitosterolemia.

Associated Symptoms

Because xanthomas are a cutaneous marker of systemic lipid abnormalities, other signs may appear depending on the underlying condition:

• Premature coronary artery disease (angina, heart attack) – especially with familial hypercholesterolemia.
• Pancreatitis – common with severe hypertriglyceridemia.
• Thyroid dysfunction symptoms (fatigue, weight gain, cold intolerance) – in hypothyroid‑related xanthomas.
• Nephrotic syndrome findings – edema, proteinuria, hypoalbuminemia.
• Liver‑related signs – jaundice, pruritus, or hepatomegaly in cholestasis.
• Systemic inflammation – low‑grade fever, arthralgias in sarcoidosis.
• Family history of early heart disease, stroke, or severe hyperlipidemia.

When to See a Doctor

Yellow plaques are rarely an emergency, but you should schedule a medical evaluation promptly if you notice:

• New‑onset plaques that are growing rapidly or spreading to multiple body sites.
• Any personal or family history of early heart attack, stroke, or high cholesterol.
• Accompanying symptoms such as chest pain, shortness of breath, or unexplained fatigue.
• Signs of pancreatitis – severe abdominal pain that radiates to the back, nausea, vomiting.
• Swelling of the legs, foamy urine, or sudden weight gain (possible nephrotic syndrome).
• Recent start of a medication known to affect lipid levels.

Diagnosis

Evaluating xanthomas involves both a visual assessment and a series of laboratory and imaging studies.

1. Clinical Examination

• Location & pattern – e.g., tendon xanthomas on Achilles or extensor tendons, eruptive xanthomas on buttocks and thighs, plane xanthomas on eyelids (xanthelasma) or neck.
• Texture – firm, papular, or nodular.
• Symmetry – bilateral involvement often suggests a metabolic cause.

2. Laboratory Tests

• Fasting lipid panel (total cholesterol, LDL‑C, HDL‑C, triglycerides).
• Lipoprotein electrophoresis for rare disorders (type III, type IV).
• Blood glucose & HbA1c (to screen for diabetes).
• Thyroid‑stimulating hormone (TSH) and free T4.
• Renal function (creatinine, urine protein quantification) if nephrotic syndrome suspected.
• Liver function tests if cholestasis is a concern.

3. Imaging & Specialized Tests

• Cardiac stress testing or coronary CT angiography if high cardiovascular risk.
• Abdominal ultrasound or CT if pancreatitis is suspected.
• Skin biopsy (rarely needed) – shows lipid‑laden macrophages (foam cells) and helps rule out mimickers such as dermatofibroma.

Guidelines from the American Heart Association and the National Lipid Association recommend a full lipid work‑up for any adult with xanthomas, regardless of age.¹

Treatment Options

Therapy is two‑fold: address the underlying lipid disorder and, if desired, remove or reduce the skin lesions**.

1. Lifestyle Interventions

• Diet: Adopt a heart‑healthy diet—rich in fruits, vegetables, whole grains, and lean protein. Limit saturated fat, trans‑fat, and simple sugars. The Mediterranean diet has strong evidence for lowering LDL-C and triglycerides (Mayo Clinic, 2023).²
• Physical activity: At least 150 minutes of moderate aerobic exercise per week improves HDL‑C and helps weight control.
• Weight management: Even modest weight loss (5‑10 % of body weight) can markedly reduce triglycerides.
• Alcohol moderation: Alcohol raises triglyceride levels; limit to ≤1 drink/day for women and ≤2 drinks/day for men.
• Smoking cessation: Smoking damages blood vessels and worsens lipid profiles.

2. Pharmacologic Therapy

• Statins (e.g., atorvastatin, rosuvastatin): First‑line for high LDL‑C; reduce cardiovascular events and can cause gradual regression of tendon xanthomas.³
• Ezetimibe: Blocks intestinal cholesterol absorption; useful when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab): Strong LDL‑C reduction, especially in heterozygous FH; case series show rapid disappearance of xanthomas.
• Fibrates (gemfibrozil, fenofibrate): Lower triglycerides; indicated for eruptive xanthomas linked to severe hypertriglyceridemia.
• Omega‑3 fatty acid prescription products (e.g., icosapent ethyl): Reduce triglycerides and may lower cardiovascular risk.
• Niacin: Can raise HDL‑C and lower triglycerides, but side effects limit its use.
• Adjuncts for secondary causes: Levothyroxine for hypothyroidism, glucose‑lowering agents for diabetes, immunosuppressive dose adjustments for drug‑induced dyslipidemia.

3. Direct Lesion Management

• Observation: Small, asymptomatic xanthomas often regress once lipid levels are controlled.
• Laser therapy (e.g., CO₂ or pulsed dye laser): Effective for superficial plane xanthomas, especially on the face or neck.
• Surgical excision: Reserved for large, bothersome nodules (e.g., tendon xanthomas) when they impair function.
• Cryotherapy or radiofrequency ablation: Emerging options; limited long‑term data.

4. Follow‑up & Monitoring

After initiating treatment, lipid panels should be rechecked at 4‑6 weeks, then every 3‑6 months. Imaging for cardiovascular disease may be repeated based on risk stratification (ACC/AHA guideline 2022).⁴

Prevention Tips

• Screen family members early—genetic testing for FH is recommended for first‑degree relatives.
• Maintain a heart‑healthy diet and regular exercise throughout life.
• Control weight, blood pressure, and blood sugar; these factors synergistically worsen lipid abnormalities.
• Avoid medications known to raise triglycerides (e.g., high‑dose estrogen, certain antiretrovirals) unless medically necessary.
• Schedule routine lipid panels at least once every 5 years for adults over 20, or more frequently if risk factors exist.
• Stay vaccinated against hepatitis B and C—chronic liver disease can precipitate secondary dyslipidemia.

Emergency Warning Signs

References:
1. Grundy SM, et al. 2023 ACC/AHA Guideline on the Management of Blood Cholesterol. Circulation. 2023.
2. Mayo Clinic. “Mediterranean diet: A heart-healthy approach.” Updated 2023.
3. Raal FJ, et al. Efficacy of PCSK9 inhibitors in familial hypercholesterolemia. NEJM. 2022.
4. National Lipid Association. “Clinical Recommendations for Lipid Management.” 2022.
5. CDC. “Cholesterol and Heart Disease.” Accessed May 2024.
6. NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Xanthomas.” 2023.